Company Overview

Company Overview

BioHealthonomics Inc. is a clinical stage biotechnology & healthcare company dedicated to developing and commercializing high-impact, effective therapeutics that address critical unmet needs in the treatment of migraine headaches, Parkinson’s disease, Alzheimer’s disease, ALS and other CNS conditions.  The company plans to develop both a product (histamine dihydrochloride) and an industry unique, proprietary technology for the treatment and prevention of these conditions. BioHealthonomics Inc. began operations in July 2011 in Santa Monica, California.

Indications such as migraine headaches, Alzheimer’s disease, Parkinson’s disease and ALS are each in need of treatments that address the root cause of the condition.  Through its proprietary technology, BioHealthonomics has developed an industry unique technology that in addition to treating the conditions, it will also prevent them from recurring.

BioHealthonomics Inc. intends on advancing its therapies to provide patients with safe and effective treatments in the care of their conditions that address the indications from a fundamental stand point while creating a win-win scenario for patients, doctors, investors, insurance companies and the U.S. healthcare system.